Supply of equipment for Emirates Biotech Pharmaceutical Factory L.L.C.
Emirates Biotech Pharmaceutical Factory L.L.C. is inviting offers from all experienced suppliers to participate in this tender to provide the factory
with the full range of equipment and accessories. To acquire the tender’s technical documents please login to: www.ebpf-uae.com Companies with intention to participate in bidding must pay A non-refundable fee of 15,000 US Dollars ( Fifteen Thousand US Dollars ) by December 15th, 2010. Bidders are welcome at the factory head offices in Abu Dhabi, Bain Al Jisrain,
beside Mercedes service center.
For more information, please contact:
Emirates Biotech Pharmaceutical Factory L.L.C.
USD Account Number:
Union National Bank
Abu Dhabi, United Arab Emirates
Emirates Biotech Pharmaceutical Factory L.L.C. is based in Abu Dhabi. Planning to produce pharmaceutical raw material based on biotechnology process, it is the first company to have access to the technology in the Middle East.
The project is divided into two phases. The first phase – approximately 124 million USD – is the finished formulation products based on API growth hormones and other growth factors and Alpha/Beta Interferon and creating the facility to manufacture anti‐cancer vaccines. The company has tied up with GL Rapha, Korea for technological assistance, manufacturing and marketing. Phase one will be completed by 2012.
The second phase – 117 million USD – is to produce API crystals insulin. Phase two will be completed by end of 2013 according to project plan.
Emirates Biotech Pharmaceutical Factory L.L.C. was established by prestigious founders, well renowned businessmen, and esteemed international partners. Emirates Biotech Pharmaceutical Factory L.L.C. has signed with GL Rapha and Hankook Corus Pharm, two pharmaceutical companies based in Seoul, South Korea, to construct the factory and market the products.
For more information about Emirates Biotech Pharmaceutical Factory L.L.C. please visit: www.ebpf-uae.com